Maciej Giefing

Institute of Human Genetics — Poland

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index2.2kcitations92works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(25), Lymphoma Diagnosis and Treatment(22), Cancer-related gene regulation(16), Cancer-related molecular mechanisms research(15), Epigenetics and DNA Methylation(14)

Publications92 total

Alginate encapsulated cell blocks improve diagnostic consistency and long term specimen integrity in routine pathological diagnostics and cancer research
Scientific Reports·2025Open Access
470 | EFFECT OF BCOR FRAMESHIFT MUTATIONS ON ITS EXPRESSION IN LYMPHOMA CELL LINES
Hematological Oncology·2025Open Access
MiRNA signature analysis in LSCC gene expression profiles indicates hsa-miR-299-5p as a new tumor suppressor
Journal of Applied Genetics·2025Open Access
Long read sequencing identifies complex structural variant landscape and recurrent TERT rearrangements in mucoepidermoid carcinoma
Oral Oncology·2024· 1 citedOpen Access
DNA methylation dysregulation patterns in the 1p36 region instability
Journal of Applied Genetics·2024Open Access
FISH and FICTION in Lymphoma Research
Methods in molecular biology·2024
HPV-driven oncogenesis—much more than the E6 and E7 oncoproteins
Journal of Applied Genetics·2024· 16 citedOpen Access
The Origin of Hodgkin Lymphoma
ACADEMIA - The magazine of the Polish Academy of Sciences·2024Open Access
Towards effectiveness of cell free DNA based liquid biopsy in head and neck squamous cell carcinoma
Scientific Reports·2024· 11 citedOpen Access
hsa-miR-299-5p - a new tumor suppressor in LSCC
Zenodo (CERN European Organization for Nuclear Research)·2023Open Access
hsa-miR-299-5p - a new tumor suppressor in LSCC
Zenodo (CERN European Organization for Nuclear Research)·2023Open Access
Transcriptional reprogramming by mutated IRF4 in lymphoma
Nature Communications·2023· 16 citedOpen Access
Deregulated hsa‐miR‐23a‐3p and hsa‐mir‐148a‐3p influence key processes in classic Hodgkin lymphoma (cHL) pathogenesis
Hematological Oncology·2023Open Access
Identification of two unannotated miRNAs in classic Hodgkin lymphoma cell lines
PLoS ONE·2023· 1 citedOpen Access
Obituary—Pieter Van Vlierberghe (1980–2022)
Leukemia·2023Open Access
A new type of transcriptional reprogramming by an IRF4 mutation in lymphoma
2022· 1 citedOpen Access
MIR142 Sanger sequencing results in MPNs
Zenodo (CERN European Organization for Nuclear Research)·2022Open Access
MIR142 Sanger sequencing results in MPNs
Zenodo (CERN European Organization for Nuclear Research)·2022Open Access
Mutations in the miR-142 gene are not common in myeloproliferative neoplasms
Scientific Reports·2022· 11 citedOpen Access
Global DNA Methylation Profiling Reveals Differentially Methylated CpGs between Salivary Gland Pleomorphic Adenomas with Distinct Clinical Course
International Journal of Molecular Sciences·2022· 2 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Krzysztof Szyfter(20), Małgorzata Jarmuż‐Szymczak(17), Katarzyna Kiwerska(16), Reidar Grénman(16), Reiner Siebert(15), Małgorzata Wierzbicka(15), Ralf Küppers(13), Magdalena Kostrzewska‐Poczekaj(12), Joanna Janiszewska(12), Martin‐Leo Hansmann(10), Marcin Szaumkessel(10), Julia Paczkowska(10), José I. Martı́n-Subero(9), Sylvia Hartmann(9), Andrzej Marszałek(9), Anna Bartochowska(9), Wolfram Klapper(8), Kinga Bednarek(8), Magdalena Bodnar(8), Adam Ustaszewski(8)